This result is supported by clinical evidence, as the concentrations of both CCL2 and CCL5 have been reported to be significantly elevated in T2DM patients compared to healthy controls (Pan et al., 2021; Wu and Ma, 2024). Here, CCL5 is linked to type 2 diabetes mellitus.